Wednesday, August 2, 2017

Pharma Reviews: Vigilant India against Chinese acquisition as deal with Shanghai Fosun Pharmaceutical Group ...

Reportedly, Chinese firm Shanghai Fosun Pharmaceutical Group's proposal of $1.3 billion take over of the Indian drug maker Gland Pharma has ...
Read more: Vigilant India against Chinese acquisition as deal with Shanghai Fosun Pharmaceutical Group ...